Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Boston Scientific Corporation (BSX)

42.63   0.34 (0.8%) 11-19 16:01
Open: 42.36 Pre. Close: 42.29
High: 42.725 Low: 42.07
Volume: 4,740,509 Market Cap: 59419M
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 42.768 - 42.938 42.938 - 43.084
Low: 41.598 - 41.808 41.808 - 41.99
Close: 42.276 - 42.62 42.62 - 42.916

Technical analysis

as of: 2019-11-19 4:24:47 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 50.80     One year: 59.33
Support: Support1: 40.02    Support2: 37.87
Resistance: Resistance1: 43.49    Resistance2: 50.80
Pivot: 41.36
Moving Average: MA(5): 42.05     MA(20): 41.26
MA(100): 41.58     MA(250): 39.32
MACD: MACD(12,26): 0.49     Signal(9): 0.29
Stochastic oscillator: %K(14,3): 78.65     %D(3): 75.66
RSI: RSI(14): 65.30
52-week: High: 43.84  Low: 31.56  Change(%): 25.2
Average Vol(K): 3-Month: 716082  10-Days: 576806

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
BSX has closed below upper band by 5.3%. Bollinger Bands are 4.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Global Cardiovascular Surgery Devices and Equipment Market Report 2019-2020 Featuring Abbott Laboratories, Boston Scientific, Cook Medical, C.R.Bard and Abiomed -
DUBLIN--(BUSINESS WIRE)--The "Cardiovascular Surgery Devices And Equipment Global Market Report 2020" report has been added to's offering. The global cardiovascular surgery devices and equipment market was valued at about $27.23 billion in 2018 and is expected to grow to $35.69 billion at a CAGR of 7.0% through 2022. The cardiovascular surgery devices and equipment market consists of sales of cardiovascular surgery devices and related services. Cardiovascular surgery devi

Outlook on the Global Urinary Incontinence & Pelvic Organ Prolapse Devices & Equipment Market, 2020-2030 -
DUBLIN--(BUSINESS WIRE)--The "Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Global Market Report 2020" report has been added to's offering. The global urinary incontinence & pelvic organ prolapse devices and equipment market was valued at about $0.5 billion in 2018 and is expected to grow to $0.63 billion at a CAGR of 6.1% through 2022. Major players in the market are Boston Scientific Corporation, Coloplast Group, Ethicon US, Bard Inc. (Becto

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 1390.00
Shares Float (M) 1390.00
% Held by Insiders 0.25
% Held by Institutions 93.40
Shares Short (K) 14360
Shares Short P. Month (K)

Stock Financials

EPS 0.770
Book Value (p.s.) 6.960
PEG Ratio 2.37
Profit Margin 10.49
Operating Margin 17.14
Return on Assets (ttm) 4.7
Return on Equity (ttm) 12.1
Qtrly Rev. Growth 13.1
Gross Profit (p.s.) 5.029
Sales Per Share
EBITDA (p.s.) 1.971
Qtrly Earnings Growth -70.80
Operating Cash Flow (M) 1160.00
Levered Free Cash Flow (M) 476.38

Stock Valuations

P/E 55.38
P/E Growth Ratio 0.01
P/BV 6.13
P/S 5.70
P/CF 51.09

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.